Focal adhesion kinase as a new player in the biology of onco-hematological diseases: the starting evidence DOI Creative Commons
Guido Capasso, Nayla Mouawad,

Maria Castronuovo

et al.

Frontiers in Oncology, Journal Year: 2024, Volume and Issue: 14

Published: Aug. 30, 2024

Focal adhesion kinase (FAK) is a non-receptor tyrosine mainly found in the focal regions of plasma membrane and it has crucial role migration remodeling cellular morphology. FAK also linked to several aspects cancer biology, from cytokine production angiogenesis, drug resistance, invasion, metastasis, as well epithelial-to-mesenchymal transition. The gene locus frequently amplified human tumors, thus causing overexpression cancers. Furthermore, can influence extracellular matrix exosome secretion through cancer-associated fibroblasts, an important tumor microenvironment regulation. Although solid tumors known, its importance onco-hematological diseases remains poorly explored. This review collects studies related significance their microenvironments. Overall, blood increasingly evident, but further research required confirm new therapeutic target hematological contexts.

Language: Английский

Discovery of Noncovalent Diaminopyrimidine-based Inhibitors for Glioblastoma via a Dual FAK/DNA Targeting Strategy DOI
Yi Wei, Xiaoling He,

Zhiwu Long

et al.

European Journal of Medicinal Chemistry, Journal Year: 2025, Volume and Issue: 286, P. 117288 - 117288

Published: Jan. 16, 2025

Language: Английский

Citations

1

Discovery of 2,4-diaminopyrimidine derivatives as potent inhibitors of FAK capable of activating the Hippo pathway for the treatment of esophageal squamous cell carcinoma DOI
Xiao Wang,

Yin-Ru Li,

Ji Wu

et al.

European Journal of Medicinal Chemistry, Journal Year: 2025, Volume and Issue: 287, P. 117328 - 117328

Published: Feb. 2, 2025

Language: Английский

Citations

1

Thienopyrimidine: A promising scaffold in the development of kinase inhibitors with anticancer activities DOI
Yunhe Liu, Ziyue Wang, Yifei Du

et al.

Bioorganic & Medicinal Chemistry, Journal Year: 2025, Volume and Issue: unknown, P. 118109 - 118109

Published: Feb. 1, 2025

Language: Английский

Citations

1

Development of Novel Focal Adhesion Kinase (FAK) Inhibitors for Targeting Cancer: Structural Insights and Therapeutic Potential DOI
Yingnan Li,

Yuming Zhang,

Jifa Zhang

et al.

European Journal of Medicinal Chemistry, Journal Year: 2024, Volume and Issue: 279, P. 116913 - 116913

Published: Sept. 26, 2024

Language: Английский

Citations

4

The recent advance of PROTACs targeting BCR-ABL for the treatment of chronic myeloid leukemia DOI

Zhuo Qian,

Yi‐Ru Bai,

Wenjuan Zhou

et al.

Bioorganic Chemistry, Journal Year: 2025, Volume and Issue: 156, P. 108189 - 108189

Published: Jan. 20, 2025

Language: Английский

Citations

0

Discovery of Potent Focal Adhesion Kinase (FAK) Inhibitor A8 with Enhanced Antitumor Activity DOI
Ye Li, Yong He, Chenyu Zhang

et al.

European Journal of Medicinal Chemistry, Journal Year: 2025, Volume and Issue: unknown, P. 117593 - 117593

Published: April 1, 2025

Language: Английский

Citations

0

Design, synthesis and biological evaluation of coumarin-containing 2,4-diphenylpyrimidine derivatives as novel focal adhesion kinase inhibitors for treatment of non-small cell lung cancer DOI

Mengrong Lei,

Hanxue Huang,

Jiayi Li

et al.

Bioorganic & Medicinal Chemistry Letters, Journal Year: 2025, Volume and Issue: 123, P. 130240 - 130240

Published: April 12, 2025

Language: Английский

Citations

0

ALK-based dual inhibitors: Focus on recent development for non-small cell lung cancer therapy DOI

Qiu-Ge Liu,

Ji Wu, Ziyue Wang

et al.

European Journal of Medicinal Chemistry, Journal Year: 2025, Volume and Issue: 291, P. 117646 - 117646

Published: April 17, 2025

Language: Английский

Citations

0

Next-Generation Cancer Therapeutics: PROTACs and the Role of Heterocyclic Warheads in Targeting Resistance DOI
Effat Omar, Rajendiran Rajesh, Pronoy Kanti Das

et al.

European Journal of Medicinal Chemistry, Journal Year: 2024, Volume and Issue: 281, P. 117034 - 117034

Published: Nov. 8, 2024

Language: Английский

Citations

1

Discovery of A Potent Anticancer Agent against Pancreatic Ductal Adenocarcinoma Targeting FAK with DFG-out State and JAK/Aurora Kinases DOI

Rong‐Hong Zhang,

Ting Chen,

Qianqian Xiong

et al.

European Journal of Medicinal Chemistry, Journal Year: 2024, Volume and Issue: 282, P. 117059 - 117059

Published: Nov. 15, 2024

Language: Английский

Citations

1